Table 2 Clinical data after primary Epstein–Barr virus infection in this subject
From: Primary Epstein–Barr virus infection shortly after primary Cytomegalovirus infection: a case report
Variable | Result | Reference range | Variable | Result | Reference range |
|---|---|---|---|---|---|
Peripheral blood | Blood biochemistry | ||||
White blood cells (/μL) | 6860 | 3300–8600 | Total protein (g/dL) | 7.4 | 6.6–8.1 |
Neutrophils (%) | 19.0 | 52.0–80.0 | Albumin (g/dL) | 4.0 | 4.1–5.1 |
Eosinophils (%) | 0.0 | 1.0–5.0 | Globulin (g/dL) | 3.4 | 2.2–3.4 |
Basophils (%) | 0.0 | 0.0–1.0 | Cholinesterase (U/L) | 182 | 240–486 |
Monocytes (%) | 6.0 | 1.0–6.0 | Total bilirubin (mg/dL) | 1.9 | 0.4–1.5 |
Lymphocytes (%) | 73.0 | 20.0–40.0 | AST (U/L) | 379 | 13–30 |
Atypical lymphocytes (%) | 2.0 | ALT (U/L) | 381 | 10–42 | |
Red blood cells (×104/μL) | 686 | 435–555 | LDH (U/L) | 650 | 124–222 |
Hemoglobin (g/dL) | 13.6 | 13.7–16.8 | ALP (U/L) | 1060 | 106–322 |
Platelets (×104/μL) | 15.5 | 15.8–34.8 | γ-GTP (U/L) | 291 | 13–64 |
Congealing fibrinogenolysis system | BUN (mg/dL) | 10 | 8–20 | ||
PT (seconds) | 11.9 | 9.3–12.5 | Creatinine (mg/dL) | 0.62 | 0.65–1.07 |
PT-INR | 1.03 | 0.85–1.13 | Uric acid (mg/dL) | 4.8 | 2.6–5.5 |
PT activity (%) | 94.9 | 80.7–125.2 | Plasma glucose (mg/dL) | 140 | |
APTT (seconds) | 39.6 | 26.9–38.1 | Total cholesterol (mg/dL) | 182 | 142–248 |
Fibrinogen (mg/dL) | 229 | 160–380 | Sodium (mmol/L) | 137 | 138–145 |
Potassium (mmol/L) | 3.9 | 3.6–4.8 | |||
Chloride (mmol/L) | 101 | 101–108 | |||
CRP (mg/dL) | 0.57 | < 0.14 | |||